Vstm is developping a cure for lukeimia
Commentaire:
Vstm is developing a cure for leukemia. They are on the verge of being FDA approved. Once this is done they will be selling in the US market. They plan on attacking the European market after sales start rolling in America. Now is the perfect time to purchase shares since they are cheap. My prediction is a 400% return from now to the end of the year.
Transaction en cours:
The approval by the FDA is schedualed for october 10th